1 al transmission is estimated below 4% of the
cumulative incidence.
2 incidence ratios, excess absolute risks, and
cumulative incidences.
3 ients relative to Ki/SPK recipients: 10-year
cumulative incidences 0.36 (95% confident interval 0.33-
4 a substantially higher risk for HCC (10-year
cumulative incidence,
13.60%) than patients with a low m
5 iated with an increased rate of TMN (10-year
cumulative incidence,
14.1% v 4.3% for those with and wi
6 iovascular causes was more frequent (10-year
cumulative incidence,
14.6% [95% CI, 13.7%-15.4%] for br
7 spital following self-harm during childhood (
cumulative incidence 21.4% [95% CI 19.8-23.1]).
8 erpersonal violence injury during childhood (
cumulative incidence 25.0% [95% CI 21.2-28.9]).
9 , 1.3 to 1.6) and respiratory complications (
cumulative incidence,
27% v 20%; HR, 1.4; 95% CI, 1.2 to
10 alizations or death with infections (10-year
cumulative incidence,
31% v 22%; HR, 1.4; 95% CI, 1.3 to
11 thout NNAs, 64 (29%) developed an inhibitor (
cumulative incidence,
34.0%; 95% CI, 27.1%-40.9%).
12 s with a low metabolic risk profile (10-year
cumulative incidence,
4.83%; adjusted-hazard ratio, 2.32
13 r advanced stage at first diagnosis (15-year
cumulative incidence,
5.3% v 3.9% and 3.9%, respectively
14 Cumulative incidence after a 5-year period was high for
15 Main Outcomes and Measures:
Cumulative incidence and hazard ratios (HRs) for SMN and
16 Age-specific incidence and
cumulative incidence and median age at the detection of
17 de the late effects of cancer therapy) using
cumulative incidence and piecewise exponential models to
18 The
cumulative incidence and prevalence of endocrine abnorma
19 To estimate the 6-year
cumulative incidence and progression of AMD in older adu
20 d conventional vaccines compare, in terms of
cumulative incidence and rates of antigenic evolution of
21 To determine the
cumulative incidence and the prognostic factors of ileor
22 We estimated dementia and AD risk (
cumulative incidence)
and studied factors associated wit
23 Cumulative incidences as of age 70 were estimated accoun
24 Cumulative incidences at 10, 15, and 20 years rose linea
25 The
cumulative incidences at age 50 years among CCSS low-ris
26 erall morbidity compared with currently used
cumulative incidence based analytic methodologies, and w
27 and 10-year overall survival (OS) and crude
cumulative incidence (
CCI) of local recurrence (LR) and
28 y variables that independently decreased the
cumulative incidence (
CI) of chronic graft-versus-host d
29 Subsequent neoplasm 15-year
cumulative incidence,
cumulative burden, and standardize
30 Cumulative incidence curves and prevalence estimates qua
31 We computed stratified
cumulative incidence curves by age (60-64, 65-69, 70-75
32 ditions is more appropriately represented by
cumulative incidence data.
33 io 1.91 [95% CI 1.63-2.25]; adjusted 10-year
cumulative incidence difference 14.1 [95% CI 10.1-18.0]
34 The
cumulative incidence estimates of grades 2-4 and 3-4 acu
35 At 2 years, the
cumulative incidence estimates of nonrelapse mortality a
36 At 6, 18, and 30 months, the
cumulative incidence estimates of SCD were 0.79%, 1.65%,
37 g Kaplan-Meier for overall survival (OS) and
cumulative incidence for biochemical recurrence (BcR), d
38 The estimated
cumulative incidence for CDA in the Denver general popul
39 Five-year
cumulative incidence for LR was 39% and for DR was 24%.
40 = 0.5 versus > 0.5 ng/mL, 5-year and 10-year
cumulative incidences for BcR were 42% versus 56% and 60
41 a 22q11.2 deletion or duplication, IRR, and
cumulative incidences for psychiatric diagnoses (Interna
42 hazards for the possible outcomes, then the
cumulative incidence function for a given candidate usin
43 Cumulative Incidence Function was used to calculate AIDS
44 cidence of outcomes, analysts should use the
cumulative incidence function, rather than the complemen
45 or modeling the effect of covariates on the
cumulative incidence function.
46 We used
cumulative incidence functions to compare temporal chang
47 Cumulative incidence functions were used for GSS analysi
48 Cumulative incidence functions were used to describe the
49 Cumulative incidence functions were used to estimate the
50 ue to clinical worsening was estimated using
cumulative incidence functions, where transplantation wa
51 ning, unbiased estimates are available using
cumulative incidence if the screen arm stops screening a
52 To estimate the
cumulative incidence in the Denver general population, o
53 We used Kaplan-Meier methods to analyse the
cumulative incidence,
incidence proportion, and incidenc
54 Cumulative incidence increased markedly after the age of
55 creen trials and population settings, excess
cumulative incidence is persistently biased.
56 The 10-year
cumulative incidence metastases rates were 5.5%, 15.0%,
57 12 months, and at 12 months, as well as the
cumulative incidence occurring between 3 and 12 months.
58 elanoma experienced local recurrence, with a
cumulative incidence of 11%.
59 udden cardiac death during follow-up, with a
cumulative incidence of 22% at 1 year and 26% at 5 years
60 sidual urinary incontinence, equivalent to a
cumulative incidence of 23.1 per 1000 person-years (14.0
61 0 days following induction, for an estimated
cumulative incidence of 3.7% (95% confidence interval [C
62 netic risk, whereas high-risk patients had a
cumulative incidence of 31%.
63 osed in 23,980 individuals, translating to a
cumulative incidence of 32%.
64 ts subsequently developed an inhibitor for a
cumulative incidence of 45.4% (95% confidence interval [
65 [CI], 1.2-4.2) per 1000 infant-months and a
cumulative incidence of 5.2 cases (95% CI, 2.6-9.0) per
66 urrent fistulas occurred, corresponding to a
cumulative incidence of 71 per 1000 person-years (95% CI
67 ccurred in 94 and 49 patients, with a 2-year
cumulative incidence of 79.2% (95% confidence interval [
68 Annual
cumulative incidence of 9-valent vaccine types was 19% a
69 a median follow-up period of 6.3 years, the
cumulative incidence of a subsequent diagnosis with celi
70 The
cumulative incidence of a subsequent meningioma by age 4
71 The
cumulative incidence of ACE increased by 16.5% per Gy (9
72 The primary end point was
cumulative incidence of ACEs within 9 years of follow-up
73 The
cumulative incidence of acute grade III-IV GVHD was 12%.
74 The
cumulative incidence of admission to a SNF ranged from 1
75 Gray model was used to measure the burden of
cumulative incidence of AIDS-related mortality and stren
76 We also assessed the 3-year
cumulative incidence of all fracture locations (excludin
77 The
cumulative incidence of all inhibitors was 26.8% (95% co
78 After 35 years of follow-up, the
cumulative incidence of all-cause dementia in the MI coh
79 Through 2 years, the unadjusted
cumulative incidence of all-cause mortality (16.0% versu
80 Cumulative incidence of all-cause mortality at 2 years i
81 Cox proportional hazards models, we compared
cumulative incidence of all-cause mortality, device-rela
82 Cumulative incidence of AMD increased with age (>/=80 ye
83 oncentrations of 8-10 mug fHb/g had a higher
cumulative incidence of AN (33%) than participants with
84 , those born between January and April), the
cumulative incidence of an ADHD diagnosis was greatest f
85 Groups with high
cumulative incidence of anal cancer may benefit from scr
86 to assess temporal trends, and estimated the
cumulative incidence of anal cancer to measure absolute
87 not find any significant differences at the
cumulative incidence of anti-TG2A positivity (hazard rat
88 The
cumulative incidence of anxiety and depression during th
89 Cumulative incidence of any first (35.5% versus 69.0%; P
90 .5% (CI, 2.8% to 8.1%) in the 5- and 10-year
cumulative incidence of any fracture, respectively.
91 Cumulative incidence of any neuroendocrine deficit at 5
92 The
cumulative incidence of any type of CD at 40 years of ag
93 The
cumulative incidence of AR at 1 year was 58% and 21% amo
94 The
cumulative incidence of AR was lower in eHF-C (risk rati
95 The 6-month
cumulative incidence of arterial thromboembolism was 4.7
96 who received mechanical valves had a higher
cumulative incidence of bleeding and, in some age groups
97 By the age of 45 years, the
cumulative incidence of breast cancer in sarcoma and leu
98 The 30-year
cumulative incidence of breast cancer in women diagnosed
99 over a median follow-up of 96 months, with a
cumulative incidence of breast cancer mortality at 10 ye
100 The
cumulative incidence of cancer estimated up to 64 years
101 Cumulative incidence of cardiac events (CE) and left ven
102 The 2-year
cumulative incidence of cardiac events was 0.28 (95% CI,
103 However, the 5-year
cumulative incidence of CBC remained significantly highe
104 isk factors for celiac disease, we found the
cumulative incidence of CDA and celiac disease to be hig
105 For each genotype, the
cumulative incidence of CDA and celiac disease were dete
106 The
cumulative incidence of CE at 6 years was slightly highe
107 We aimed to estimate the
cumulative incidence of celiac disease in adolescents bo
108 Cumulative incidence of chronic GVHD at 1 year was signi
109 The
cumulative incidence of chronic GVHD was 29%; relapse, n
110 After a median follow-up of 24 months, the
cumulative incidence of chronic GVHD was 32.2% (95% conf
111 multivariable-adjusted differences in 5-year
cumulative incidence of CKD in underweight, overweight,
112 new vertebral fracture at 24 months and the
cumulative incidence of clinical fracture (nonvertebral
113 The
cumulative incidence of clinically relevant bleeding (ma
114 Five-year
cumulative incidence of complications such as graft reje
115 aplan-Meier method was used to calculate the
cumulative incidence of corneal edema.
116 In addition, the
cumulative incidence of CVD events in the highest quarti
117 The
cumulative incidence of death after a bleeding event amo
118 The
cumulative incidence of death after an ischemic event am
119 re comorbidities in recent years, the 3-year
cumulative incidence of death or major cardiovascular ev
120 The
cumulative incidence of death was lower for patients wit
121 ivariable modeling were used to estimate the
cumulative incidence of death, transplant, and echocardi
122 The primary outcome was the
cumulative incidence of delirium, assessed bid using the
123 Cumulative incidence of developing new neuroendocrine dy
124 When
cumulative incidence of diabetes was analysed by quartil
125 sceptibility for type 1 diabetes reduced the
cumulative incidence of diabetes-associated autoantibodi
126 Cumulative incidence of disengagement from care was esti
127 s 72.9% (95% CI 70.2-75.7) and 10-year crude
cumulative incidence of distant metastases was 25.0% (95
128 approved dose of 1.3 mg/m(2), the estimated
cumulative incidence of DLT was > 50%, and the estimated
129 The
cumulative incidence of dnDSA was 47% at a median of 86
130 ncidence of DLT was > 50%, and the estimated
cumulative incidence of dose reduction or treatment disc
131 Five-year
cumulative incidence of DSD was 31%, and factors indepen
132 ough evidence of an event, we determined the
cumulative incidence of each event.
133 We examined the unadjusted
cumulative incidence of each outcome studied from hospit
134 death at 10 years after diagnosis, when the
cumulative incidence of each was 5%.
135 The 6-year weighted (for loss to follow-up)
cumulative incidence of early AMD was 164.2 per 1000 per
136 At 10 years,
cumulative incidence of EBRT was 5.9% (SE +/- 3), and ev
137 Primary outcome was
cumulative incidence of eczema by 12 months in infants r
138 Secondary outcomes were
cumulative incidence of eczema by 12 or 18 months in all
139 The
cumulative incidence of eczema was reduced in pHF-W (RR
140 The
cumulative incidence of epilepsy was 24.7% (95% CI 16.2-
141 The
cumulative incidence of epilepsy was lower in patients w
142 Prognostic analyses focused on
cumulative incidence of failure (including primary refra
143 We described the
cumulative incidence of first disengagement (>180 days n
144 Conclusion The 24-month
cumulative incidence of grade >/= 3 cardiac events excee
145 The
cumulative incidence of grade 2 to 4 acute GVHD at day 1
146 The
cumulative incidence of grade 3-4 hearing loss at 3 year
147 Cumulative incidence of grade II to IV acute GvHD was 22
148 The
cumulative incidence of grade III to IV acute graft-vers
149 The 100-day
cumulative incidence of grade III-IV acute GVHD on univa
150 ratio, 5.06; 95% CI, 2.23-11.47) and 10-year
cumulative incidence of HCC (25.0% in smokers with 3 or
151 risk factors had significant differences in
cumulative incidence of HCC and liver-related death.
152 In a post hoc analysis, the 2-year
cumulative incidence of hematological relapse was 33.5%
153 7 to 54.3) with recombinant factor VIII; the
cumulative incidence of high-titer inhibitors was 18.6%
154 skull, toes, and fingers) and falls, 10-year
cumulative incidence of hip fracture alone, and nonverte
155 The 10-year
cumulative incidence of hip fracture in all recipients w
156 ogic transformation at diagnosis, the 5-year
cumulative incidence of histologic transformation was 2%
157 odel with delayed entry was used to estimate
cumulative incidence of histologically proven cSCC and t
158 rtion of ICD recipients enrolled in hospice,
cumulative incidence of hospice admission, and factors a
159 The
cumulative incidence of hospitalizations was 65.4%, rang
160 The 12-month
cumulative incidence of HR-HPV detection was 25.4% (95%
161 The 20-year
cumulative incidence of IBTR in 1616 patients (160 event
162 The
cumulative incidence of incisional hernias at 2-year fol
163 Cumulative incidence of infection at 1 year post implant
164 Results RT reduced the
cumulative incidence of ipsilateral breast tumor recurre
165 The 6-month
cumulative incidence of ischemic stroke was 3.0% (95% CI
166 to 18 months, hazard ratio [HR] = 2.69) and
cumulative incidence of leukemic evolution (from 0% to 4
167 e survival (EFS), overall survival (OS), and
cumulative incidence of local progression (CILP).
168 east irradiation had a local recurrence; the
cumulative incidence of local recurrence was 1.44% (95%
169 The
cumulative incidence of LTP at 12-month follow-up was 22
170 The two-year
cumulative incidence of lymphedema was as follows: 4.08%
171 n-treated group (HR 0.97, 95% CI 0.77-1.22);
cumulative incidence of major bleeding was 0.3% (95% CI
172 At 5 years of follow-up, the
cumulative incidence of mesh-related complications was 5
173 The
cumulative incidence of metastatic prostate cancer at 12
174 Cumulative incidence of MI was assessed over 3 months af
175 648 randomly assigned patients, the monthly
cumulative incidence of MI was lower with continued thie
176 The 5-year
cumulative incidence of mortality was 11.65% under obser
177 0, 4.3 years), the overall 1-year and 5-year
cumulative incidence of mortality was 13.5% (95% confide
178 The 6-month
cumulative incidence of myocardial infarction was 2.0% (
179 The
cumulative incidence of National Institutes of Health (N
180 Univariate survival regression on the
cumulative incidence of NC identified period of transpla
181 The unadjusted
cumulative incidence of NEC at week 8 among RBC transfus
182 The
cumulative incidence of new blindness and sight impairme
183 The primary end points were the
cumulative incidence of new vertebral fracture at 24 mon
184 The
cumulative incidence of nodal recurrences at 10 years wa
185 Cumulative incidence of nonrelapse mortality at 1 year w
186 Four patients died, the
cumulative incidence of nonrelapse mortality being 5%, w
187 ear overall survival was 83%, and the 1-year
cumulative incidence of nonrelapse mortality was 14%.
188 The
cumulative incidence of nonrelapse mortality was 16% by
189 Recipients had a higher 3-year
cumulative incidence of nonvertebral fracture (1.6%; 95%
190 ged 50 years or older had the highest 3-year
cumulative incidence of nonvertebral fracture (3.1%; 95%
191 databases to estimate the 3-, 5- and 10-year
cumulative incidence of nonvertebral fracture (proximal
192 Eligible studies describing the
cumulative incidence of OIs and proportion on ART from 1
193 To determine the
cumulative incidence of optic disc hemorrhage (ODH) befo
194 The primary outcome was
cumulative incidence of ototoxicity at 3 years, graded w
195 esized that the relationship between sex and
cumulative incidence of PAD differed according to age.
196 Although the
cumulative incidence of partial remission was lower in t
197 The
cumulative incidence of PAS per 100000 pregnant/postpart
198 During 12 months of surveillance, the
cumulative incidence of patients undergoing 3 or more CA
199 -2009 vs 91% in 2010-2012 (P = .95), and the
cumulative incidence of patients undergoing more than 1
200 The
cumulative incidence of POAG in eyes with ODH was 25.6%
201 The
cumulative incidence of pre-engraftment GNB was 17.3% in
202 In 305 women at risk of pregnancy, the
cumulative incidence of pregnancy was 106.0 per 1000 per
203 Measurements: Weekly and
cumulative incidence of prenatal infections and microcep
204 ns to delay pregnancy by 9 to 24 months, the
cumulative incidence of prenatal Zika virus infections i
205 n follow-up time of 3.4 years, the estimated
cumulative incidence of progression at 4 years is 19% (9
206 veloped late AMD at follow-up, with a 6-year
cumulative incidence of progression from early to late A
207 , or decrease in category and to compare the
cumulative incidence of progression in category.
208 The
cumulative incidence of progression to a malignant categ
209 The
cumulative incidence of progression to at least category
210 The 5-year
cumulative incidence of PTM in patients with and without
211 We estimated the
cumulative incidence of reaching a particular cascade st
212 The
cumulative incidence of receiving a second shock was 14.
213 Cumulative incidence of recurrences was estimated with c
214 The
cumulative incidence of rejection episodes was significa
215 The 5-year
cumulative incidence of relapse (+/- standard error) was
216 Five-year
cumulative incidence of relapse (CIR) and disease-free s
217 e survival (EFS), overall survival (OS), and
cumulative incidence of relapse (CIR).
218 m peripheral blood-MRD (PB-MRD) had a higher
cumulative incidence of relapse (subhazard ratio [SHR],
219 Gain in RFS could be related to the lower
cumulative incidence of relapse observed in the CLARA ar
220 MUD, respectively, and corresponding 2-year
cumulative incidence of relapse or progression was 39%,
221 te 87%, 5-year survival rate 92%, and 5-year
cumulative incidence of relapse rate 8%) compared with p
222 urvival rate was 99% (SE 1%), and the 5-year
cumulative incidence of relapse rate was 6% (SE 2%).
223 The
cumulative incidence of relapse was 7.5% at 5 years.
224 -up of 40.6 months, the event-free survival,
cumulative incidence of relapse, and overall survival at
225 5%, whereas 19 relapsed, resulting in a 24%
cumulative incidence of relapse.
226 +/- 3% vs 89% +/- 4%; Plog-rank = .71), and
cumulative incidence of relapse/nonresponse (CIR/NR; 6%
227 Cumulative incidence of relapse/progression at 3 years w
228 At 2 years, the
cumulative incidence of repeated overdose was 17% (95% C
229 othesized that BCG at birth would reduce the
cumulative incidence of RW during the first year of life
230 The
cumulative incidence of SCD and cardiovascular death was
231 The 5-year
cumulative incidence of SCD was 8.5%.
232 calculated standardized incidence ratios and
cumulative incidence of second cancer in HL survivors an
233 The
cumulative incidence of second primary malignancies at 6
234 verse events and stroke was <1%, whereas the
cumulative incidence of serious adverse events and muscu
235 nic health conditions, such that the 15-year
cumulative incidence of severe or life-threatening chron
236 cant differences in either the proportion or
cumulative incidence of side-effects 5 years after treat
237 The
cumulative incidence of skin-only, grade 1-2 acute GVHD
238 The 20-year
cumulative incidence of SMN with death as a competing ri
239 Main Outcomes and Measures:
Cumulative incidence of speech/language, scholastic, or
240 l, population-based cohort study, we found a
cumulative incidence of strabismus consistent with those
241 Cumulative incidence of subsequent all-cause mortality w
242 The
cumulative incidence of sudden death at 90 days after ra
243 The
cumulative incidence of surgery at 30 days, 6 months, 1
244 At age 50 years, the
cumulative incidence of survivors experiencing at least
245 Ultimately, they had a very low 5-year
cumulative incidence of T1D.
246 The
cumulative incidence of the primary outcome was 3.08% (9
247 In the external cohort, the
cumulative incidence of therapy-related myeloid neoplasm
248 The
cumulative incidence of therapy-related myeloid neoplasm
249 The absolute difference in
cumulative incidence of type 2 DM between the lowest and
250 Cumulative incidence of VF was estimated and competing r
251 During follow-up, the
cumulative incidence of violence-related arrest for pati
252 s (median follow-up 6 months), a significant
cumulative incidence of weight loss between baseline and
253 iate sensitivity analyses indicated that the
cumulative incidence of ZIKV infection and risk of micro
254 We aimed to determine the
cumulative incidence of/risk factors for long-term cance
255 survivors had significantly greater 10-year
cumulative incidences of all major organ-system outcomes
256 The
cumulative incidences of breast cancer at age 55 were 3.
257 The 1-, 5-, 10-, and 20-year
cumulative incidences of cancer were 2.1%, 8.6%, 18.7%,
258 th UDCA, OCA+UDCA could decrease the 15-year
cumulative incidences of decompensated cirrhosis from 12
259 s who did not receive ADT, had higher 3-year
cumulative incidences of depression (7.1% v 5.2%, respec
260 To compare the 1-year
cumulative incidences of events when events were identif
261 Cumulative incidences of graft failure, cytomegalovirus,
262 The
cumulative incidences of initial grades I-IV, II-IV, and
263 Five-year crude
cumulative incidences of local recurrence and distant me
264 Cumulative incidences of molecular relapse by 12 and 48
265 The
cumulative incidences of postoperative complications wer
266 analogues indefinitely yielded 1- and 3-year
cumulative incidences of recurrence, defined by positive
267 The 2-year
cumulative incidences of relapse/progression among patie
268 The primary outcomes were the
cumulative incidences of symptomatic venous thromboembol
269 dence rate ratios (IRRs; relative risks) and
cumulative incidence percentage values (absolute risks)
270 0.4%, whereas the highest stress group had a
cumulative incidence proportion of approximately 1.2%.
271 The lowest stress group had a
cumulative incidence proportion of either receiving trip
272 The
cumulative incidence rate of a second primary malignancy
273 Cumulative incidence rate of first alcohol relapse was 2
274 The 8-year
cumulative incidence rate of secondary malignancies was
275 Cumulative incidence rate/100,000 population (CIR) of ne
276 The
cumulative incidence rates of all-cause death were not s
277 By 3 years, the
cumulative incidence rates of mortality and readmission
278 recurrent MI modeled as competing risks, the
cumulative incidence rates of post-MI HF among patients
279 e versus placebo or observation, whereas the
cumulative incidence rates of progression, death, or dea
280 The
cumulative incidence rates of sudden death were assessed
281 Cumulative incidence rates were calculated using competi
282 Outcomes were
cumulative incidence (
risk) and risk ratio of new-onset
283 We estimated
cumulative incidence,
risk factors, and mortality from d
284 xial length and spherical equivalent, with a
cumulative incidence (
SE) of visual impairment of 3.8% (
285 Triggered campaigns reduce the highest
cumulative incidence seen in simulations by up to 80%.
286 uartile range, 6 to 24 months), and 24-month
cumulative incidence was 11% (95% CI, 5% to 16%).
287 nd had follow-up images gradable for GA, the
cumulative incidence was 12% at 1 year, 17% at 2 years,
288 d 273 composite CVD events occurred, and the
cumulative incidence was 18.4%, 16.5%, 20.6%, and 29.8%
289 vascular death, and repeat revascularization
cumulative incidence was 2.3% (95% confidence interval [
290 Five-year AML
cumulative incidence was 20.3%, 20.3%, and 11.3% for tho
291 Among APOE-e4/e4 individuals, 5-y
cumulative incidence was as follows: in the 60-64-y age
292 Cumulative incidence was calculated with death considere
293 mately 20% for high-risk groups ( P < .001);
cumulative incidence was only 1% for siblings ( P < .001
294 The
cumulative incidence was similar in nonusers compared wi
295 Overall,
cumulative incidence was uniformly higher in NACC than i
296 By use of the
cumulative incidence,
we estimated 5- and 10-year risks
297 83.2), and 5-year estimates of local relapse
cumulative incidence were 1.1% (95% CI 0.5-2.3) of patie
298 Kaplan-Meier estimates of the
cumulative incidence were generated.
299 ators of 22q11.2 deletion or duplication and
cumulative incidences were estimated using a nested case
300 Relative to non-black women, the
cumulative incidences were increased in black women (68%